Journal
JOURNAL OF LIPID RESEARCH
Volume 49, Issue 5, Pages 995-1005Publisher
ELSEVIER
DOI: 10.1194/jlr.M700503-JLR200
Keywords
damage; myelin; Alzheimer's disease; brain lipids
Categories
Ask authors/readers for more resources
Unlike F-4-neuroprostanes (F-4-NeuroPs), which are relatively selective in vivo markers of oxidative damage to neuronal membranes, there currently is no method to assess the extent of free radical damage to myelin with relative selectively. The polyunsaturated fatty acid adrenic acid (AdA) is susceptible to free radical attack and, at least in primates, is concentrated in myelin within white matter. Here, we characterized oxidation products of AdA as potential markers of free radical damage to myelin in human brain. Unesterified AdA was reacted with a free radical initiator to yield products (F-2-dihomo-IsoPs) that were 28 Da larger than but otherwise closely resembled F-2-isoprostanes (F-2-IsoPs), which are generated by free radical attack on arachidonic acid. Phospholipids derived from human cerebral gray matter, white matter, and myelin similarly oxidized ex vivo showed that the ratio of esterified F-2-dihomo-IsoPs to F-4-NeuroPs was similar to 10-fold greater in myelin-derived than in gray matter-derived phospholipids. Finally, we showed that F-2-dihomo-IsoPs are significantly increased in white matter samples from patients with Alzheimer's disease. We propose that F-2-dihomo-IsoPs may serve as quantitative in vivo biomarkers of free radical damage to myelin from primate white matter.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available